The HLA-I landscape confers prognosis and antitumor immunity in breast cancer

In conclusion, we presented an overview of HLA-I indicators in breast cancer and provided hints for precision treatment for low-Pr TNBCs.PMID:38602320 | PMC:PMC11007120 | DOI:10.1093/bib/bbae151

Source: Briefings in Bioinformatics - April 11, 2024 Category: Bioinformatics Authors: Xiao-Hong Ding Yi Xiao Fenfang Chen Cheng-Lin Liu Tong Fu Zhi-Ming Shao Yi-Zhou Jiang Source Type: research